Researcher.Life Logo

GaBI Journal : Impact Factor & More

eISSN: 2033-6772pISSN: 2033-6403

Key Metrics

CiteScore
2.2
H-Index
15
SJR
Q3Pharmacy
SNIP
0.61
Recommended pre-submission checks
Powered by Paperpal by Editage

GaBI Journal Journal Specifications

Overview
Publisher PRO PHARMA COMMUNICATIONS INT
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2011
Website URLVisit website
View less

Planning to publish in GaBI Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in GaBI Journal

Biosimilars in oncology: beyond regulation—building confidence through evidence and dialogue
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Title not available
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Rising costs of biologicals: effective cost-containment does not please all stakeholders
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Australian biosimilar policies not delivering on intended outcomes: where to from here?
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Effective and safe handling of pre-filled syringe (PFS) for administration of biosimilar candidate AVT06 (aflibercept) in patients with chorioretinal vascular diseases
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Barriers to expanding biosimilars in oncological indications in Chile: A value-chain approach to understand visions and propose recommendations for improving value proposition
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Biosimilars in oncology: beyond regulation—building confidence through evidence and dialogue
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Title not available
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Rising costs of biologicals: effective cost-containment does not please all stakeholders
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Australian biosimilar policies not delivering on intended outcomes: where to from here?
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Effective and safe handling of pre-filled syringe (PFS) for administration of biosimilar candidate AVT06 (aflibercept) in patients with chorioretinal vascular diseases
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal
Barriers to expanding biosimilars in oncological indications in Chile: A value-chain approach to understand visions and propose recommendations for improving value proposition
  • 15 Dec 2025
  • Generics and Biosimilars Initiative Journal

FAQs on GaBI Journal